Abingworth as of June 30, 2016
Portfolio Holdings for Abingworth
Abingworth holds 20 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals | 19.0 | $18M | 1.3M | 13.91 | |
| Proteon Therapeutics | 17.0 | $16M | 2.0M | 8.06 | |
| Sientra | 15.2 | $15M | 2.2M | 6.58 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 7.7 | $7.4M | 589k | 12.52 | |
| Cempra | 6.6 | $6.3M | 384k | 16.49 | |
| Chiasma | 6.3 | $6.0M | 2.1M | 2.89 | |
| Lombard Med (EVARF) | 4.0 | $3.8M | 3.5M | 1.09 | |
| Innocoll | 3.2 | $3.1M | 556k | 5.52 | |
| Dicerna Pharmaceuticals | 3.0 | $2.8M | 946k | 2.99 | |
| Cymabay Therapeutics | 2.9 | $2.8M | 1.6M | 1.75 | |
| Cellectis S A (CLLS) | 2.8 | $2.7M | 100k | 26.59 | |
| Dermira | 2.1 | $2.0M | 70k | 29.24 | |
| Adaptimmune Therapeutics (ADAP) | 2.1 | $2.0M | 250k | 8.13 | |
| Senseonics Hldgs (SENS) | 2.1 | $2.0M | 517k | 3.92 | |
| Immune Design | 1.7 | $1.6M | 197k | 8.16 | |
| Aurinia Pharmaceuticals (AUPH) | 1.4 | $1.4M | 512k | 2.71 | |
| Anthera Pharmaceutcls | 1.4 | $1.3M | 438k | 3.08 | |
| Regulus Therapeutics | 1.0 | $943k | 327k | 2.88 | |
| OncoGenex Pharmaceuticals | 0.4 | $400k | 396k | 1.01 | |
| Epirus Biopharmaceuticals In | 0.0 | $4.0k | 7.9k | 0.51 |
